Default Theme
AIIMS NEW
-
अखिल भारतीय आयुर्विज्ञान संस्थान, नई दिल्ली
All India Institute Of Medical Sciences, New Delhi

DR. AJAY GOGIA

 

Curriculum Vitae

Dr. Ajay Gogia, MD, DM, is an Associate Professor in the Department of Medical Oncology at Dr. B.R.A Institute-Rotary Cancer Hospital All India Institute of Medical Sciences (AIIMS), New Delhi, India. He received his  M.B.B.S, MD (Internal Medicine) degree from Banaras Hindu University, DM (Medical Oncology) from AIIMS, New Delhi. He has over 14 year of working and teaching experience in Medical Oncology and specializes in Breast Cancer & Non-Hodgkin’s Lymphoma patient care and research. He has gained  his  International exposure  in Europe , North America , UK and Canada.His research is well published with more than 100 peer reviewed articles in National and International oncology journals and is well cited. He has received Dronacharya Award in the field of Oncology for his excellence

 

Name                                                    :               Dr. Ajay Gogia

Qualifications                                         :               MBBS,

                                                                             MD (Internal Medicine),

                                                                             DM (Medical Oncology)

 

Current Appointment                    :                          Associate Professor

                                                                            Department of Medical Oncology,

                                                                            Dr. B.R.A, I.R.C.H,

                                                                            All India Institute of Medical Sciences (AIIMS)

                                                                            Ansari Nagar, New Delhi, 110029

 

Nationality                                          :                  Indian 

Education and Qualifications :  

Degree

University

Year

MBBS

Institute of Medical Sciences, Banaras Hindu University, Varanasi-India

2000

M.D.(Internal Medicine)

Institute of Medical Sciences, Banaras Hindu University, Varanasi-India

2003

D.M. (Medical Oncology)

All India Institute of Medical Sciences

(AIIMS), New Delhi, India

2011

  Working place and post : 

Post

University/ INSTITUTE

Year

Senior Residency and D.M ( Medical Oncology)

All India Institute of Medical Sciences

(AIIMS), New Delhi, India

2006-11

Senior Research Associate

(Pool Officer)

All India Institute of Medical Sciences

(AIIMS), New Delhi, India

2011-12

Assistant Professor

All India Institute of Medical Sciences

(AIIMS), New Delhi, India

2013- 17

Associate Professor

All India Institute of Medical Sciences

(AIIMS), New Delhi, India

2017- till date

 

Working&TEACHING experienec in medical oncology: 14 years

 

 Specific Area of Interest

OPD Schedule and timing

Member of the multidisciplinary teams of Breast cancer clinic (BCC) and lymphoma clinic at Dr. B.R.A-IRCH, All India Institute of Medical Sciences (AIIMS)and taking care of Medical Management of Breast cancer, B-cell Non Hodgkin lymphoma especially in low grade lymphoma and CLL

Breast Cancer

 

Monday (2.00pm, Breast cancer clinic, Board Room).Wednesday and Friday (9.30 am, Adult Medical Oncology clinic, Board Room)

Non-Hodgkin Lymphoma  and Chronic lymphocytic leukemia  (CLL)

Thursday (2.00 pm, LL clinic, Room No. 4), Wednesday and Friday (9.30 am, Adult Medical Oncology Clinic, Board Room)

 

 Fellowship

PLACE

Year

Indian American cancer Association-(IACA) Fellowship

Cleveland Clinic. OHIO, United States of America (USA)

Mentor: Prof. Jame Abraham

2016

European Society Of Medical Oncology (ESMO) Fellowship

Jules Bordet Hospital, Brussels

Mentor: Prof. Martine Piccart

2017

 

MD Anderson Cancer center (MDACC)

MDACC, Houston, Texas,USA

Mentor :Prof. Hagop M.Kantarjian / Prof. Jain

2018

ESMO-  Palliative care visit

 

Princess Margaret Cancer Centre Toronto,Canada

Mentor : Prof. Subratha Banerjee

2019

 

Awards/Honors

PLACE

Year

Best Poster Award  on  Safety and Efficacy of Bendamustine /Rituximab in Indian CLL patients

ESMO, Barcelona

2019

Dronacharya-CME Award  in Oncology

New Delhi by  Minister of Health and welfare ( Mr. Ashwini Chaubey)

2019

 

International Oncology Research   scholarship/grant

PLACE

Year

American Association of Cancer Research (AACR)/Australia & Asia Pacific Clinical Oncology Research Development (ACORD)

Sydney, Australia

2018

INDOX Cancer Research Network

University of Oxford, United Kingdom ( UK)

2012

European Society Of Medical Oncology (ESMO)- Translational unit visit

Christie NHS Foundation Trust, Manchester, United Kingdom ( UK)

2012

European School of Oncology –Master class in clinical Oncology

Ermatingen, Switzerland

2012

 

 

Observer- ship 

PLACE

Year

ESO-Short term in-house observer ship

The Royal Marsden Hospital, London UK

2019

Short term in-house observer ship

Sarah Cannon Center, Nashville, USA

2017

Principle- Investigator ( PI)

A phase III Open label Randomized study to compare the efficacy of Lenalidomide - Rituximab (LR) vsBendamustine –Rituximab (BR) in treatment naïve follicular lymphoma(CTRI/2016/05/006904 [Registered on: 06/05/2016] )

A Prospective, Multicenter, Randomized, Double-blind, Parallel group Study to Compare the Efficacy and Safety of GBR 200 (Similar biologic of Trastuzumab) versus Innovator Trastuzumab, both when Given in Combination with Paclitaxel in Patients Diagnosed with HER2 Positive Metastatic Breast Cancer

Protocol ID: GBR 200-301

A phase II randomized study of the combination of Ribociclib plus goserelin

acetate with Hormonal Therapy versus physician choice chemotherapy in premenopausal or perimenopausal patients with hormone receptor positive/HER2-negative inoperable locally  advanced or metastatic breast cancer - RIGHT Choice Study.

Co- Investigator ( CO-PI)

A Phase III, Randomized, Open-Label, Two-Arm Study of Neratinib Plus Paclitaxel Versus Trastuzumab Plus Paclitaxelas First Line Treatment for ErbB-2-Positive Locally Recurrent or Metastatic Breast Cancer.3144A2-3005-WW (Wyeth)

A Phase III, Randomized, Open-Label, Two-Arm Study of Neratinib Plus Paclitaxel Versus Trastuzumab Plus Paclitaxelas First Line Treatment for ErbB-2-Positive Locally Recurrent or Metastatic Breast Cancer.3144A2-3005-WW (Wyeth)

A Phase III, Open Label, Randomized Multicenter Trial of Ofatumumab-Chlorambucil combination Vs. ChlorambucilMonotherapy in previously untreated patients with Chronoic Lymphocytic Leukemia”. Protocol: OMB110911. 

OMB110913 - A Phase III, Open Label, Randomized Trial of Ofatumumab added to Fludarabine-Cyclophosphamide Vs. Fludarabine-Cyclophosphamide Combination in Subjects with Relapsed Chronic Lymphocytic Leukemia

EGF105485 (TEACH):A Randomized, Double-blind, Multicenter, Placebo-controlled Study of Adjuvant Lapatinib in Women with Early-Stage ErbB2 Overexpressing Breast Cancer.

ATLAS (Adjuvant Tamoxifen Long Against Short): A major international trial funded by Oxford University, UK

A randomized, multi-center, open-label, phase III study of Adjuvant Lapatinib, Trastuzumab, their sequence and their combination in patients with HER2/ErbB2 positive primary breast cancer.” (ALTTO Study)

Axitinib (AG-013736) as second line therapy for metastatic renal cell cancer: axis trial. Sponsored by Pfizer.

A Study of TrastuzumabEmtansine Versus Capecitabine + Lapatinib in Participants With HER2-positive Locally Advanced or Metastatic Breast Cancer (EMILIA)

A Multi Centre, Pilot Phase II Trial Assessing The Efficacy And Safety Of Bevacizumab + Gemcitabine + Carboplatin AsFirst Line Treatment For Patients Diagnosed With Triple Negative Metastatic Breast Cancer (Protocol No. ML 25420) 

Setting up Hospital Based Cancer Registries ( HBCRs)  and  Pattern of Care and Survival Studies on Breast Cancer

 

Others

CLINICAL PROJECT – AS A CO- INVESIGATOR with Different super/sub specialties in AIIM (20 in number)

International scholarship/young investigator award to present oral presentation =3

DM-Medical Oncology Teaching curriculum &  Exam Coordinator: Since 2013

Active participation in teaching including MBBS/MD/DM/ MSc Nursing Student  

Active Participation in FREE Medical Camp organized by AIIMS or Govt. of India at LEH and DHARAMSHALA

Regular Participating in patient awareness programme in DOORDARSHAN & RAJSABHA TV

 

 CURRENT MEMBERSHIPS IN PROFESSIONAL SOCIETIES  

  • Members in American Society of Clinical Oncology-(ASCO ID -10476)
  • European Society of Medical Oncology- ESMO-ID-(82716)  

PUBLICATIONS: More than100(Name highlighted)

 

 

In press:

  • Gogia A,  Nigade j,  Desai C,  Govind BK,  Deshmukh C,  Swarup BTrastuzumab emtansine: Antibody-drug conjugate in treatment of human epidermal growth factor receptor-2-positive metastatic breast cancer. Indian Journal of Medical and Paediatric Oncology
  • Gupta VG,  Gogia A, Kumar L  , Sharma A, et al Combined modality treatment with “dexamethasone, methotrexate, ifosfamide, l-asparaginase, and etoposide” chemotherapy and involved field radiotherapy for early stage natural …Indian Journal of Medical and Paediatric Oncology
  • Talpua R, Kakkanattu TJ, KumarA,  Gogia A,  WigN.A Case of Idiopathic CD4 Lymphocytopenia (ICL): Immunological Mystery Leading to Storm of Diseases.
  • Journal of Clinical & Diagnostic Research 11 (12)
  • SVS Deo, NK Shukla, A Gogia, DN Sharma, A Jakhetiya, DK MudulyA Comparative Study of Clinical Profile and Relapse Patterns in TRIPLE-NEGATIVE and Non-Triple-Negative Breast Cancer Patients Treated with Curative Intent
  • Indian Journal of Surgical Oncology 8 (3), 291-297

 

POSTER / ORAL PRESENTATION – abstracts  

  • A Gogia, L Kumar, A Sharma, V Raina, R Gupta, L Rani. 1085P Safety and efficacy of bendamustine and rituximab (BR) regimen in Indian chronic lymphocytic leukemia patients. Annals of Oncology 30 (Supplement_5), mdz251. 020
  • A Gogia, L Kumar, A Sharma, R Gupta, L Rani. Incidence and outcome of chronic lymphocytic leukemia with deletion 17p: An Indian experience; challenges and opportunities. Annals of Oncology 30 (Supplement_5), mdz269. 055
  • N Das, A Malhotra, R Gupta, S Rai, SK Gupta, RK Sahoo, A Gogia.  CD123 is an Important Predictor of Post Induction Response and Early Treatment Outcome in Acute Lymphoblastic Leukemia. Clinical Lymphoma, Myeloma and Leukemia 19, S197
  • S Mallick, A Panda, MR Lone, A Goswami, P Ramteke, MC Sharma, Gogia A.ClinicopathologicalProfileof Primary Double Expressor Lymphoma. Clinical Lymphoma, Myeloma and Leukemia 19, S257
  • N Das, A Malhotra, R Gupta, S Rai, S Singh, RK Sahoo, A Gogia.Role of CD123 as Determinant of Minimal Residual Disease in Acute Myeloid Leukemia. Clinical Lymphoma, Myeloma and Leukemia 19, S235
  • A Kakkar, S Purkait, S Agarwal, S Mallick, A Gogia, AK Karak, MC Sharma.Primary thyroid lymphoma: A series from a tertiary care center in Northern India. Journal of cancer research and therapeutics 15 (3), 669 2019
  • A Gogia, R Gupta, A Sharma, L Kumar, V Raina, L Rani. Chronic lymphocytic leukemia: An Indian experience. Journal of Clinical Oncology 37 (15_suppl), e19007-e19007 2019
  • KR Soti, L Kumar, R Saxena, S Bakhshi, A Gogia, PS Malik, R Sahoo. Characteristics and outcomes of Philadelphia chromosome-negative myeloproliferative neoplasm in a tertiary institute in India: An ambispective study. Journal of Clinical Oncology 37 (15_suppl), e18553-e185532019
  • M Sharma, A Gogia, SVS Deo, NK Shukla, S Thulkar, R Kumar, D SharmaProfile of metastatic breast carcinoma: Single center experience from a developing country. Journal of Clinical Oncology 36 (15_suppl), e13102-e13102……2018
  • M Sharma, A Gogia, SVS Deo, NK Shukla, D Sharma, S Thulkar, R KumarEstrogen receptor (ER), progesterone receptor (PR) and Her2neu receptor expresssion: Change from baseline to first metastasis in breast cancer—Single center experience from … Journal of Clinical Oncology 36 (15_suppl), e13095-e1309, 2018
  • SK Paikaray, A Gogia, L Kumar, A Sharma, A Biswas, MC SharmaA phase III open label randomized study to compare the efficacy of lenalidomide-rituximab vs bendamustine-rituximab in treatment naive follicular lymphoma. Journal of Clinical Oncology 36 (15_suppl), e19552-e19552…….2018
  • A Biswas, L Kashyap, N Adhikari, A Gogia, R Sahoo, A Sharma. Secondary central nervous system lymphoma clinical experience from a regional cancer centre in India. Radiotherapy and Oncology 127, S692…2018
  • L Rani, M Dahiya, N Mathur, R Gupta, A Gogia, L Kumar, A Sharma.Detection of genetic aberrations in CLL using multiplex ligation-dependent probe amplification (MLPA). LEUKEMIA & LYMPHOMA 58, 176-177..2017
  • Bilateral Breast Cancer-Incidence, Clinical Spectrum And Challenges In The Management. SVS Deo, NK Shukla, A Gogia. Journal of Cancer Research & Therapeutics 13. 2017
  • Criteria For Pathological Complete Response (Pcr) Cr And Its Impact On Relapse Rates In Breast Cancer Patients Undergoing Neo-Adjuvant Chemotherapy- SVS Deo, NK Shukla, A Gogia. Journal of Cancer Research & Therapeutics 13. 2017
  • Elucidation of miRNAs associated with disease progression and response in chronic lymphocytic leukemia L Rani, R Gupta, N Mathur, K Singh, A Gogia, D Sundar, L Kumar, et.al. LEUKEMIA & LYMPHOMA 58, 173-174….2017
  • Detection of genetic aberrations in CLL using multiplex ligation-dependent probe amplification (MLPA) L Rani, M Dahiya, N Mathur, R Gupta, A Gogia, L Kumar, A Sharma. LEUKEMIA & LYMPHOMA 58, 176-177….2017
  • Patterns of Loco-Regional Relapse in Curatively Treated Locally Advanced Breast Cancer (LABC) Patients: A Single Centre Retrospective Study. A Jakhetiya, SS Deo, NK Shukla, A Gogia, D Sharma, D Muduly, S Mathur et.al.  ANNALS OF SURGICAL ONCOLOGY 24, S50-S50…2017
  • 18FDG PET-CT–SUV correlation with molecular subtypes in locally advanced/recurrent breast carcinoma. SK Bhoriwal, SVS Deo, NK Shukla, P Garg, R Kumar, A Gogia. European Journal of Cancer 72, S22…2017
  • 356P Early stage natural killer/T cell lymphoma with local tumor invasiveness treated with a uniform SMILE protocol: An institutional study from India. VG Gupta, A Gogia, P Mehta, L Kumar, A Sharma, S Bakhshi, S Thulkar. Annals of Oncology 27 (suppl_9)..2016
  • 335O Imatinib trough levels: A potential biomarker to predict cytogenetic and molecular response in newly diagnosed patients with chronic myeloid leukemia. H Natarajan, L Kumar, S Bakhshi, A Sharma, T Velpandian, A Gogia et.al.Annals of Oncology 27 (suppl_9).. Page 586  2016
  • 256. A prospective study comparing conventional investigation and PET-CT scan for staging in locally advanced breast carcinoma. S Bhoriwal, S Deo, R Kumar, NK Shukla, S Thulkar, A Gogia, DN Sharma, et.al. European journal of Surgical Oncology Volume 42,Issue 42, Issue 9, Pages S138
  • Bone marrow involvement in mantle cell lymphoma: An immunophenotyping analysis with clinicopathologic correlation from a tertiary care center in North India. CK Das, L Kumar, A Gogia, R Kaushal. European Journal of Surgical Oncology 42 (9), S138..2016
  • Role of 18F-FDG PET/CT in the management of patients with primary breast lymphoma.
  • S Taywade, R Kumar, A Behera, N Damle, M Tripathi, A Gogia, CS Bal. Journal of Clinical Oncology 34 (15_suppl), e19073-e19073
  • Autologous stem cell Transplantation (ASCT) for Multiple Myeloma (MM): Predictors of long term outcome. L Kumar, RR Boya, R Pai, B Sainath, RK Sahoo, PS Malik, A Mookerjee, A Gogia. Journal of Nuclear Medicine 57 (supplement 2), 1623-1623…2016
  • Non-Hodgkin lymphoma unclassifiable between diffuse large B-cell lymphoma and Burkitt lymphoma. A Singh, S Purkait, A Gogia, S Mallick. Clinical Lymphoma, Myeloma and Leukemia 15, e146-e147
  • Impact of DNA methylation and gene expression profile on treatment initiation and treatment free survival in early stage CLL. R Gupta, L Rani, N Mathur, A Gogia, D Sundar, A Sharma, L Kumar. Clinical Lymphoma, Myeloma and Leukemia 15, e145-e146
  • RR Boya, S Bakhshi, A Gogia, RK Sahoo, L Kumar. Prediction of poor mobilization of Peripheral Blood Stem Cells (PBSC) with G-CSF alone, in multiple myeloma (MM) patients undergoing autologous transplantation.Clinical Lymphoma, Myeloma and Leukemia 15, 171-72
  • Nasal NK-T cell lymphoma: 10-year experience of a single institute in India. P Mehta, V Raina, L Kumar, A Sharma, S Bakhshi, A Gogia, T Tvsvgk. Journal of Clinical Oncology 32 (15_suppl), 19536
  • VinodRaina, Ajay Gogia, B. K. Mohanti, S. V. S. Deo, N. K. Shukla, Vishnu kumarSreenivas Breast cancer in the young (≤35 years): A single center study from the All India Institute of Medical Sciences. Journal of Clinical Oncology 31,no.15_suppl10.1200/jco.2013.31.15_suppl.e12539
  • CLINICO‐PATHOLOGICAL PROFILE AND CMYC IMMUNOREACTIVITY OF ALK POSITIVE LARGE B CELL LYMPHOMA: REPORT OF NINE CASES S Mallick, MR Lone, P Ramteke, S Purokait, A Gogia. Hematological Oncology Volume 35, Issue S2,Page 395-6
  • Impact of DNA methylation and gene expression profile on treatment initiation and treatment free survival in early stage CLL. Ritu Gupta, Lata Rani, NitinMathur, Ajay Gogia, DuraiSundar, Atul Sharma, Lalit Kumar. Journal of Clinical Oncology 33 (15_suppl), e22073- e22073
  • 18FDG PET-CT–SUV correlation with molecular subtypes in locally advanced/recurrent breast carcinoma SK Bhoriwal, SVS Deo, NK Shukla, P Garg, R Kumar, A Gogia, DN Sharma, S Thulkar, S Mathur. Hematological Oncology Volume 35, Issue S2, Pages, 395-396
  • Role of FDG PET–CT (Positron Emission Tomography and Computed Tomography) scan in the staging of locally advanced/recurrent breast cancer as a single modality.. Pankaj Kumar Garg, SV SuryanarayanaDeo, Rakesh Kumar, Nootan Kumar Shukla, Sanjay Thulkar, Ajay Gogia, Dayanand Sharma, Sandeep R Mathur. Journal of Clinical Oncology Volume 33 e11508
  • Publisher American Society of Clinical Oncology
  • CK Das, A Garg, A Gogia. 533P Docetaxel induced cutaneous toxicity in breast cancer patients.Annals of Oncology Volume 27Issuesuppl_9 …2016
  • Prashant Mehta, VinodRaina, Lalit Kumar, Atul Sharma, Sameer Bakhshi, Ajay Gogia, TilakTvsvgk, BivasBiswas, SiddharthSahai, Surendra Pal Chaudhary, Vijay Murugan, Mehar C Sharma, SandeepMathur, Sanjay Thulkar. Nasal NK-T cell lymphoma: 10-year experience of a single institute in India.Journal of Clinical Oncology Volume 32Issue 15_suppl Pages e19536 Publisher American Society of Clinical Oncology
  • NatarajanHarivenkatesh, Lalit Kumar, Sameer Bakhshi, Atul Sharma, MadhulikaKabra, ThirumurthyVelpandian, Ajay Gogia, ShivaramShastri, Yogendra Kumar Gupta. Influence of MDR1 and CYP3A5 genetic polymorphisms on trough levels and therapeutic response of imatinib in patients with chronic myeloid leukemia.Cancer Research Volume76 Issue14 Supplement Pages2040-2040 Publisher American Association for Cancer Research
  • Rakesh Reddy, Atul Sharma, Sameer Bakhshi, Ajay Gogia, RanjitSahoo, ChanderPrakashYadav, Lalit Kumar. Comparison of three leukapharesis machines for harvest of stem cells for autologous transplantation: A prospective study.jOURNAL OF CLINICAL ONCOLOGY 34(15_suppl) 8024
  • SmeetaGajendra, Anita Chopra, Suman Kumar, Ajay Gogia,JaganChandramohan, Sameer Bakhshi, Atul Sharma, Lalit Kumar, Rachna Seth, RM PandeyImmunophenotypic analysis of T-lineage acute lymphoblastic leukemia. CD5 matters.LEUKEMIA & LYMPHOMA Volume 54 Pages24-24
  • H Natarajan, L Kumar, S Bakhshi, A Sharma, T Velpandian, A Gogia, YK Gupta 
  • C.K. Das, A. Gogia, N.K. ShuklaS. DeoS. MathurD. Sharma.Prognostic significance of the derived neutrophil lymphocyte ratio in metastatic breast cancer: A tertiary cancer care center analysis from India. Annals of Oncology Volume 27Issuesuppl_9 …2016 
  • C.K. Das, A. GogiaN.K. ShuklaS. DeoS. MathurD. SharmaPrognostic significance of the derived neutrophil lymphocyte ratio in metastatic breast cancer: A tertiary cancer care center analysis from India. Annals of Oncology, Volume 27, Issue suppl_9, 1 December 2016, mdw577.005,

Imatinib trough levels: A potential biomarker to predict cytogenetic and molecular response in newly diagnosed patients with chronic myeloid leukemia. Annals of Oncology Volume 27 Issue suppl_9 Page 586

 

Book Chapters

Books

  • Hormone-dependent Malignancies in Elderly: Endometrium, Breast and Prostate

 

  • Role ofAutologous Transplant in hematological Malignancies

 

  • Basics of Cancer Biology and Therapy:

Text book of Geriatric Medicine

 

 

Recent Advances in Hematology

 

 Update in Onco-Anaesthesia

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Photo gallery ( International  Fellowship)

Article in India Today Magazine ( Nov 21, 2016)

 

Photo gallery ( FREE MEDICAL CAMP AT LEH AND DHARAMSHALA)

 

 

 

Contact Us

All India Institute of Medical Sciences

Ansari Nagar, New Delhi - 110029

Board Number : +91-11-26588500 / 26588700

Fax : +91-11-26588663 / 26588641

AIIMS Exam Section Helpline numbers ( Click Here)

Important E-mail Addresses at AIIMS

Zo2 Framework Settings

Select one of sample color schemes

Google Font

Menu Font
Body Font
Heading Font

Body

Background Color
Text Color
Link Color
Background Image

Header Wrapper

Background Color
Modules Title
Text Color
Link Color
Background Image

Menu Wrapper

Background Color
Modules Title
Text Color
Link Color
Background Image

Main Wrapper

Background Color
Modules Title
Text Color
Link Color
Background Image

Inset Wrapper

Background Color
Modules Title
Text Color
Link Color
Background Image

Bottom Wrapper

Background Color
Modules Title
Text Color
Link Color
Background Image
Background Color
Modules Title
Text Color
Link Color
Background Image
 
Top of Page